【结 构 式】 |
【药物名称】Ozagrel sodium, Xanbon, Cataclot 【化学名称】(E)-p-(Imidazol-1-ylmethyl)cinnamic acid sodium salt 【CA登记号】82571-53-7 (free acid) 【 分 子 式 】C13H11N2NaO2 【 分 子 量 】250.23462 |
【开发单位】Kissei (Originator), Ono (Originator) 【药理作用】Cerebrovascular Diseases, Treatment of, NEUROLOGIC DRUGS, Thromboxane Synthase Inhibitors |
合成路线1
The condensation of ethyl 4-(bromomethyl)cinnamate (I) with imidazole (II) by means of NaH in DMF give ethyl 4-(1-imidazolylmethyl)cinnamate (III), wich is hydrolyzed with NaOH in methanol - water, and acidified with HCl.
【1】 Bergstrom, S.; Carlson, L.A.; Weeks, J.R.; The protaglandins: A family of biologically active lipids. J Med Chem 1981, 24, 10, 409-412. |
【2】 Iizuka, K.; Akahane, K.; Kamijo, Y.; Momose, D.; Matsumoto, A.; Yukiyoshi, O. (Kissei Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.); Imidazole derivative. DE 2923815; GB 2025946; US 4226878 . |
【3】 Blancafort, P.; Serradell, M.N.; Pento, J.T.; Castaner, J.; OKY-046. Drugs Fut 1983, 8, 4, 328. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 30685 | ethyl (E)-3-[4-(bromomethyl)phenyl]-2-propenoate; ethyl 4-(bromomethyl)cinnamate | C12H13BrO2 | 详情 | 详情 | |
(II) | 10255 | Imidazole; 1H-Imidazole | 288-32-4 | C3H4N2 | 详情 | 详情 |
(III) | 30686 | ethyl (E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoate; 4-(1-Imidazolylmethyl)cinnamate | C15H16N2O2 | 详情 | 详情 |
合成路线2
2-Methylimidazole (I) is converted into the bisulfate salt, and then nitrated by means of a sulfonitric mixture in Ac2O to produce 2-methyl-4-nitroimidazole (II) . In a variant of this procedure, 2-methylimidazole (I) is nitrated by using a ferric nitrate-tonsyl adduct in several solvents. Imidazole (II) is then regioselectively alkylated with boiling 2-chloroethanol to produce the title compound. Alternatively, the alkylation of (II) has been reported by treatment with ethylene oxide (III) under acidic conditions.
【1】 Frank, A.; Karn, H.; Spanig, H. (Abbott GmbH & Co. KG); Production of 1-hydroxyalkyl-5-nitroimidazoles. DE 2359625; FR 2253019; GB 1481349 . |
【2】 Frank, A.; Dockner, T.; Karn, H. (Abbott GmbH & Co. KG); Process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. EP 0150407 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|